NCT02538302

Minirin Versus Oxybutynin for Nocturnal Enuresis in Children

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Hormozgan University of Medical Sciences · Academic / Other
• Sex: All
• Age: 5 Years – 14 Years
• Healthy volunteers: Not accepted

Summary

Nocturnal enuresis is among the most common disorders in children. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.

Detailed description

Nocturnal enuresis is among the most common disorders in children. Several pharmacological and non-pharmacological treatments are available for nocturnal enuresis. Studies for reaching the best pharmacological treatment for this disorder are continuing. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.

Conditions

• Nocturnal Enuresis

Interventions

Type	Name	Description
DRUG	Minirin	Minirin 5 to 10 mg daily for 6 months
DRUG	Oxybutynin	Oxybutynin 5 to 10 mg daily for 6 months

Timeline

• Start date: 2013-07-01
• Primary completion: 2015-07-01
• Completion: 2015-08-01
• First posted: 2015-09-02
• Last updated: 2015-09-02

Locations

1 site across 1 country: Iran